Quantcast

Latest Biochip Stories

2010-09-28 13:40:00

SUNNYVALE, Calif., Sept. 28 /PRNewswire/ -- Molecular Devices, Inc., a leader in bioanalytical systems for drug discovery & development, life science research, and bioassay/test development, today announced that it is taking orders for its new IonWorks Barracuda(TM) Automated Patch Clamp System. (Logo: http://photos.prnewswire.com/prnh/20100406/SF82092LOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20100406/SF82092LOGO) Following the tradition of IonWorks®...

2010-09-27 03:54:00

BILBAO, Spain, September 27, 2010 /PRNewswire-FirstCall/ -- - LPLchip(R) Rapidly and Precisely Detects Mutations Causing LPL Deficiency, a Cause of Acute Pancreatitis - LPLchip(R) Identifies Patients who Could Benefit From Gene Therapy, Such as AMT's Glybera(R), Currently Under Review for EU Approval Progenika Biopharma S.A., a pioneer in the field of personalized medicine, announced today that it has obtained the CE Mark allowing the sale in Europe of its LPLchip(R), the...

2010-09-13 07:05:00

PARIS, September 13, 2010 /PRNewswire/ -- Biosystems International (BSI), a biotechnology company specializing in the discovery of novel monoclonal antibody based diagnostics, announces its merger with the company MicroBioChips (MBC) by contribution of assets. Advantages of the merger Following a successful partnership to develop monoclonal antibody microarrays, in which BSI provided the antibodies and MBC produced and commercialized the microarrays, the two companies have...

28b80b3afd056ced55ecf83240e91ca0
2010-08-04 13:43:43

DNA microarrays are one of the most powerful tools in molecular biology today. The devices, which can be used to probe biological samples and detect particular genes or genetic sequences, are employed in everything from forensic analysis to disease detection to drug development. Now Paul Li and colleagues at Simon Fraser University in Burnaby, Canada have combined DNA microarrays with microfluidic devices, which are used for the precise control of liquids at the nanoscale. In an upcoming...

2010-06-24 11:03:00

BARCELONA, June 24 /PRNewswire/ -- Spanish biotechnology company Progenika Biopharma, specializing in the development of personal medicine technology, has granted Grifols exclusive world-wide distribution rights for its BLOODCHIP® molecular biology products. BLOODCHIP® products are used for genotyping of blood donors to assure the compatibility of blood for transfusion between donor and recipient. Under this agreement, Grifols takes a further step...

2010-06-23 09:13:00

HEIDELBERG, Germany and LEXINGTON, Mass., June 23 /PRNewswire/ -- febit today announced a restructuring as a consequence of its strategic focus on blood-based microRNA biomarker discovery, febit's major business development in 2009/2010, and on partnerships and intellectual property (IP) commercialization. The new focus includes the collaboration and provision of high-end services for clinical researchers in academia, diagnostic companies and the pharma industry. febit's...

2010-04-06 08:00:00

ALBUQUERQUE, N.M., April 6 /PRNewswire/ -- Life BioScience, Inc. (LBSI) has launched a new Life MicroFab(TM) Division that provides a broad range of micro-fabrication services for devices made in APEX(TM) Glass, APEX(TM) Ceramic, Silicon, Pyrex(TM), SOI, Kapton(TM) and other standard materials used in the semiconductor manufacturing process. Its services are targeted at customers seeking convenient and cost efficient solutions for their micro-fabrication needs - whether they are in the...

2010-03-01 09:12:00

LEXINGTON, Mass. and HEIDELBERG, Germany, March 1 /PRNewswire/ -- febit today announced that an updated version of the company's Geniom Biochip containing 58 new discovered sequences in addition to all of the Homo sapiens microRNAs (miRNA) from miRBase version 14 (www.mirbase.org) is now available for cancer research. The 58 new miRNA sequences were found by deep sequencing in a miRNA discovery study performed on an Applied Biosystems SOLiD 3 sequencing system. All 58 miRNAs have been...

2010-02-17 09:52:00

LEXINGTON, Mass. and HEIDELBERG, Germany, Feb. 17 /PRNewswire/ -- febit today announced the launch of its HybSelector, a new instrument for high throughput targeted resequencing, at the 11th annual Advances in Genome Biology and Technology (AGBT) meeting on February 24-27, 2010, in Marco Island, Florida. AGBT is now widely regarded as the premier scientific forum for sharing information about the latest advances in new DNA sequencing technologies and their application to diverse areas in...

2010-01-20 09:42:00

LEXINGTON, Mass., and HEIDELBERG, Germany, Jan. 20 /PRNewswire/ -- The Molecular Genetics Core Facility (MGCF) at Children's Hospital Boston chose febit's HybSelect technology which will enable genetics researchers to conduct the highly economic targeted enrichment of genes of interest for resequencing. In January the core facility will be receiving the Geniom RT Analyzer® from febit to perform HybSelect. "We feel that febit's HybSelect technology will be a powerful tool...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related